Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Centessa Pharmaceuticals plc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +1 vs. Q3 2022
- Shares held
- 63.9M
- +2.09M (+3.4%) vs. Q3 2022
- Total value
- $194.4M
- −$54.3M (−21.8%) vs. Q3 2022
- New holders
- 4
- 14 more added
- Sold out
- 3
- 9 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $61.9M | 25.99% | 00.0% | Unchanged |
| General Atlantic LLC | 9,681,818 | $30.0M | 0.40% | 00.0% | Unchanged |
| BVF Inc | 6,894,345 | $21.4M | 0.90% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 5,232,279 | $16.2M | 0.49% | +1,995,927+61.7% | Added |
| Vida Ventures Advisors, LLC | 3,931,818 | $12.2M | 16.38% | 00.0% | Unchanged |
| OUP Management Co., LLC | 2,937,615 | $9.11M | 14.87% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,387,167 | $7.40M | 0.00% | −58,816−2.4% | Reduced |
| Janus Henderson Group PLC | 2,114,519 | $6.58M | 0.00% | −830,437−28.2% | Reduced |
| Tanager Wealth Management LLP | 1,878,383 | $5.82M | 1.57% | +1,878,383 | New |
| Samsara BioCapital, LLC | 1,693,736 | $5.25M | 1.13% | 00.0% | Unchanged |
| FMR LLC | 1,230,909 | $3.82M | 0.00% | +522,118+73.7% | Added |
| Franklin Resources Inc | 832,348 | $2.58M | 0.00% | −584−0.1% | Reduced |
| Kynam Capital Management, LP | 733,926 | $2.28M | 0.35% | +2,405+0.3% | Added |
| Cormorant Asset Management, LP | 561,600 | $1.74M | 0.12% | −1,411,128−71.5% | Reduced |
| American Century Companies Inc | 514,428 | $1.59M | 0.00% | −1,318−0.3% | Reduced |
| Affinity Asset Advisors, LLC | 460,328 | $1.43M | 0.65% | +217,811+89.8% | Added |
| Morgan Stanley | 315,135 | $976.9K | 0.00% | +298,641+1,810.6% | Added |
| BlackRock Inc. | 310,041 | $961.1K | 0.00% | +16,530+5.6% | Added |
| Ensign Peak Advisors, Inc | 248,228 | $769.5K | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 219,420 | $680.2K | 0.01% | +40,852+22.9% | Added |
| Oasis Management Co Ltd. | 110,000 | $341.0K | 0.07% | 00.0% | Unchanged |
| TD Asset Management Inc | 82,055 | $254.4K | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 79,700 | $247.1K | 0.00% | −38,100−32.3% | Reduced |
| Citadel Advisors LLC | 72,307 | $224.2K | 0.00% | −153,061−67.9% | Reduced |
| Manufacturers Life Insurance Company, The | 57,421 | $185.5K | 0.00% | 00.0% | Unchanged |
| Tejara Capital Ltd | 42,235 | $130.9K | 0.08% | +42,235 | New |
| Jane Street Group, LLC | 25,985 | $80.6K | 0.00% | −3,926−13.1% | Reduced |
| Tower Research Capital LLC (TRC) | 16,171 | $51.0K | 0.00% | +10,894+206.4% | Added |
| Goldman Sachs Group Inc | 14,993 | $46.5K | 0.00% | −1,536−9.3% | Reduced |
| Geode Capital Management, LLC | 13,428 | $41.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 12,747 | $39.0K | 0.00% | +9,356+275.9% | Added |
| Compagnie Lombard Odier SCmA | 5,820 | $19.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,745 | $9.00K | 0.00% | +860+45.6% | Added |
| UBS Group AG | 2,586 | $8.02K | 0.00% | +1,028+66.0% | Added |
| Bank of America Corp | 1,992 | $6.17K | 0.00% | +1,826+1,100.0% | Added |
| Adirondack Trust Co | 925 | $2.86K | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 700 | $2.17K | 0.00% | +350+100.0% | Added |
| Citigroup Inc | 668 | $2.07K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 533 | $1.65K | 0.00% | +52+10.8% | Added |
| Daiwa Securities Group Inc. | 211 | $1.00K | 0.00% | +211 | New |
| Crewe Advisors LLC | 220 | $682 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 60 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 125 | $0 | 0.00% | +125 | New |
| Boxer Capital, LLC | 1,251,137 | – | – | 00.0% | Unchanged |
| Logos Global Management LP | 0 | $0 | 0.00% | −399,801−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −51,503−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Index Venture Life Associates VI Ltd | – | – | – | – | Not filed |